UNLIMITED TURBO LONG - NOVARTIS N Share Price

Certificat

E2NMB

NLBNPNL2JCI0

Real-time Euronext Paris 07:52:53 28/06/2024 pm IST
2.722 EUR +2.95% Intraday chart for UNLIMITED TURBO LONG - NOVARTIS N
Current month+12.32%
1 month+18.30%
Date Price Change
28/24/28 2.722 +2.95%
27/24/27 2.644 -1.45%
26/24/26 2.683 -0.15%
25/24/25 2.687 -1.25%
24/24/24 2.721 +8.06%

Real-time Euronext Paris

Last update June 28, 2024 at 07:52 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying NOVARTIS AG
IssuerLogo Issuer BNP Paribas BNP Paribas
E2NMB
ISINNLBNPNL2JCI0
Date issued 13/10/2023
Strike 70.8 CHF
Maturity Unlimited
Parity 10 : 1
Emission price 1.96
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.804
Lowest since issue 1.376
Spread 0.005
Spread %0.18%

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
106.3 USD
Average target price
110.3 USD
Spread / Average Target
+3.77%
Consensus
  1. Stock Market
  2. Certificates
  3. E2NMB Certificat